ADA Polyclonal Antibody

This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID)| in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins| whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.

The ADA Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of adenosine deaminase (ADA) protein in various biological samples. This antibody is produced by immunizing rabbits with a purified recombinant ADA protein, ensuring its high affinity and specificity towards the target antigen.

With its exceptional performance, the ADA Polyclonal Antibody offers researchers a reliable and accurate means to investigate the expression and localization of ADA in tissues and cells. It is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody exhibits minimal cross-reactivity with other related proteins, ensuring precise and specific results. Its high sensitivity allows for the detection of low levels of ADA protein, making it an ideal choice for studies requiring a high level of sensitivity.

The ADA Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, ensuring cost-effectiveness and minimizing waste. The antibody is stable and can be stored at -20°C, guaranteeing long-term usability.

In summary, the ADA Polyclonal Antibody is a valuable tool for researchers in the field of immunology and molecular biology. Its high specificity, sensitivity, and stability make it an essential component for the accurate detection and quantification of ADA protein in various biological samples.